DV
Dividend Vision

ALZN — Alzamend Neuro Inc

Alzamend Neuro Inc (ALZN)

Total return is -100.0% over the past 5.2 years, 196.3 points behind SPY at 96.3%. Its deepest 1-year drawdown was 67.3%.

ALZN is an equity fund focused on Alzamend Neuro Inc, a single-stock holding established in June 2021. The fund provides direct exposure to a neuroscience-focused company without dividend distributions or a stated yield profile. With minimal available data on expense ratios and assets under management, this fund structure appeals primarily to investors seeking concentrated exposure to the underlying company rather than traditional dividend income.

ALZN key facts

Asset type
Stock
Asset class
Equity
Inception date
06/15/2021
Last close
$1.55
Market cap
$4,603,737
Average volume
87500.0
Beta
0.142
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.67